Evidence map›Paper›PMID 30581534›Full record

ArticleOxidative medicine and cellular longevity2018

Uric Acid Protects against Focal Cerebral Ischemia/Reperfusion-Induced Oxidative Stress via Activating Nrf2 and Regulating Neurotrophic Factor Expression.

Bai-Liu Ya, Qian Liu, Hong-Fang Li, Hong-Ju Cheng, Ting Yu, Lin Chen, You Wang, Li-Li Yuan, Wen-Juan Li, Wen-Yan Liu and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Effect of uric acid in animal models of ischemic stroke: A systematic review and meta-analysis.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Observational
  17. Glutathione-Mediated Neuroprotective Effect of Purine Derivatives.International journal of molecular sciences · 2023
    Review
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Bai-Liu YaDepartment of Physiology, Jining Medical University, Shandong 272067, China.ORCID 0000-0003-3805-5990
Qian LiuSchool of Clinical Medicine, Jining Medical University, Shandong 272067, China.
Hong-Fang LiDepartment of Neurology, Affiliated Hospital of Jining Medical University, Shandong 272067, China.
Hong-Ju ChengDepartment of Physiology, Jining Medical University, Shandong 272067, China.
Ting YuDepartment of Physiology, Jining Medical University, Shandong 272067, China.
Lin ChenSchool of Basic Medicine, Jining Medical University, Shandong 272067, China.
You WangSchool of Basic Medicine, Jining Medical University, Shandong 272067, China.
Li-Li YuanSchool of Basic Medicine, Jining Medical University, Shandong 272067, China.
Wen-Juan LiSchool of Forensic and Laboratory Medicine, Jining Medical University, Shandong 272067, China.
Wen-Yan LiuDepartment of Physiology, Jining Medical University, Shandong 272067, China.
Bo BaiDepartment of Physiology, Jining Medical University, Shandong 272067, China.
Jining Medical University · CNAffiliated Hospital of Jining Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate whether uric acid (UA) might exert neuroprotection via activating the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway and regulating neurotrophic factors in the cerebral cortices after transient focal cerebral ischemia/reperfusion (FCI/R) in rats. UA was intravenously injected through the tail vein (16 mg/kg) 30 min after the onset of reperfusion in rats subjected to middle cerebral artery occlusion for 2 h. Neurological deficit score was performed to analyze neurological function at 24 h after reperfusion. Terminal deoxynucleotidyl transferase-mediated dNTP nick end labeling (TUNEL) staining and hematoxylin and eosin (HE) staining were used to detect histological injury of the cerebral cortex. Malondialdehyde (MDA), the carbonyl groups, and 8-hydroxyl-2'-deoxyguanosine (8-OHdG) levels were employed to evaluate oxidative stress. Nrf2 and its downstream antioxidant protein, heme oxygenase- (HO-) 1,were detected by western blot. Nrf2 DNA-binding activity was observed using an ELISA-based measurement. Expressions of BDNF and NGF were analyzed by immunohistochemistry. Our results showed that UA treatment significantly suppressed FCI/R-induced oxidative stress, accompanied by attenuating neuronal damage, which subsequently decreased the infarct volume and neurological deficit. Further, the treatment of UA activated Nrf2 signaling pathway and upregulated BDNF and NGF expression levels. Interestingly, the aforementioned effects of UA were markedly inhibited by administration of brusatol, an inhibitor of Nrf2. Taken together, the antioxidant and neuroprotective effects afforded by UA treatment involved the modulation of Nrf2-mediated oxidative stress and regulation of BDNF and NGF expression levels. Thus, UA treatment could be of interest to prevent FCI/R injury.

Indexed as

8-Hydroxy-2'-DeoxyguanosineAnimalsBlotting, WesternBrain IschemiaCerebral InfarctionDeoxyguanosineEnzyme-Linked Immunosorbent AssayHeme Oxygenase-1ImmunochemistryIn Situ Nick-End LabelingMaleMalondialdehydeNF-E2-Related Factor 2Oxidative StressRatsRats, Sprague-Dawley8-Hydroxy-2'-DeoxyguanosineDeoxyguanosineHeme Oxygenase-1MalondialdehydeNF-E2-Related Factor 2Uric Acid

Identifiers

PMID30581534
PMCPMC6276484
OpenAlexW2900794595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.